Key discussions at the conference covered vaccine trials, where India’s large and unique birth cohort was highlighted as ideal for research. The need for AI-driven tools and upstream development in life sciences was emphasized. In medical devices, India’s USD 14 billion industry growth, MedTech parks, and frugal innovations like medical isotopes stood out.Read More
